CABR
Caring Brands, Inc. Common Stock
NASDAQ: CABR · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$0.86
-8.40% today
Updated 2026-05-08
Market cap
$14.61M
P/E ratio
—
P/S ratio
3,466.59x
EPS (TTM)
$-0.44
Dividend yield
—
52W range
$0 – $6
Volume
0.1M
Caring Brands, Inc. Common Stock (CABR) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2023 | 2024 | 2025 |
|---|---|---|---|
| Revenue | $20421.00 | $465.00 | $4215.00 |
| Revenue growth (YoY) | — | -97.7% | +806.5% |
| Cost of revenue | $118874.00 | $2072.00 | $1873.00 |
| Gross profit | $-98453.00 | $-1607.00 | $2342.00 |
| Gross margin | -482.1% | -345.6% | 55.6% |
| R&D | — | — | — |
| SG&A | — | $721214.00 | $147694.00 |
| Operating income | $-151394.00 | $-1.53M | $-5.94M |
| Operating margin | -741.4% | -328471.8% | -140807.2% |
| EBITDA | — | — | $-5.31M |
| EBITDA margin | 0.0% | 0.0% | -126003.0% |
| EBIT | — | — | $-5.61M |
| Interest expense | — | — | $19166.00 |
| Income tax | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% |
| Net income | $-128086.00 | $-1.52M | $-6.28M |
| Net income growth (YoY) | — | -1084.7% | -313.7% |
| Profit margin | -627.2% | -326329.2% | -148948.8% |